These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33430196)

  • 21. The application of allometric scaling principles to predict pharmacokinetic parameters across species.
    Huang Q; Riviere JE
    Expert Opin Drug Metab Toxicol; 2014 Sep; 10(9):1241-53. PubMed ID: 24984569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interspecies scaling for the prediction of drug clearance in children: application of maximum lifespan potential and an empirical correction factor.
    Mahmood I
    Clin Pharmacokinet; 2010 Jul; 49(7):479-92. PubMed ID: 20528008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling for the Prediction of Drug Clearance From Neonates to Adolescents.
    Mahmood I; Tegenge MA
    J Clin Pharmacol; 2019 Feb; 59(2):189-197. PubMed ID: 30192373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development.
    Mahmood I
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1177-92. PubMed ID: 17826864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of fixed coefficients and exponents in the prediction of human drug clearance: how accurate are the predictions from one or two species?
    Mahmood I
    J Pharm Sci; 2009 Jul; 98(7):2472-93. PubMed ID: 19025899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comprehensive analysis of the role of correction factors in the allometric predictivity of clearance from rat, dog, and monkey to humans.
    Nagilla R; Ward KW
    J Pharm Sci; 2004 Oct; 93(10):2522-34. PubMed ID: 15349961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling concentrations of antimicrobial drugs: comparative pharmacokinetics of cephalosporin antimicrobials and accuracy of allometric scaling in food-producing and companion animals.
    Taverne FJ; van Geijlswijk IM; Heederik DJ; Wagenaar JA; Mouton JW
    BMC Vet Res; 2016 Sep; 12(1):185. PubMed ID: 27596044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allometric pharmacokinetic scaling: towards the prediction of human oral pharmacokinetics.
    Feng MR; Lou X; Brown RR; Hutchaleelaha A
    Pharm Res; 2000 Apr; 17(4):410-8. PubMed ID: 10870984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of human pharmacokinetics of therapeutic monoclonal antibodies from simple allometry of monkey data.
    Oitate M; Masubuchi N; Ito T; Yabe Y; Karibe T; Aoki T; Murayama N; Kurihara A; Okudaira N; Izumi T
    Drug Metab Pharmacokinet; 2011; 26(4):423-30. PubMed ID: 21606605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of drug clearance in children: impact of allometric exponents, body weight, and age.
    Mahmood I
    Ther Drug Monit; 2007 Jun; 29(3):271-8. PubMed ID: 17529882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.
    Mahmood I
    Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetic principles behind scaling from preclinical results to phase I protocols.
    Mahmood I; Balian JD
    Clin Pharmacokinet; 1999 Jan; 36(1):1-11. PubMed ID: 9989339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interspecies scaling of a camptothecin analogue: human predictions for intravenous topotecan using animal data.
    Ahlawat P; Srinivas NR
    Xenobiotica; 2008 Nov; 38(11):1377-85. PubMed ID: 18946781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of human pharmacokinetics of activated recombinant factor VII and B-domain truncated factor VIII from animal population pharmacokinetic models of haemophilia.
    Larsen MS; Juul RV; Groth AV; Simonsson USH; Kristensen AT; Knudsen T; Agersø H; Kreilgaard M
    Eur J Pharm Sci; 2018 Mar; 115():196-203. PubMed ID: 29369801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical pharmacokinetics of MI-219, a novel human double minute 2 (HDM2) inhibitor and prediction of human pharmacokinetics.
    Zou P; Zheng N; Yu Y; Yu S; Sun W; McEachem D; Yang Y; Yu LX; Wang S; Sun D
    J Pharm Pharm Sci; 2012; 15(2):265-80. PubMed ID: 22579006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.
    Mahmood I
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interspecies scaling and comparisons in drug development and toxicokinetics.
    Ings RM
    Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translational Model-Based Strategy to Guide the Choice of Clinical Doses for Antibody-Drug Conjugates.
    Bouillon-Pichault M; Brillac C; Amara C; Nicolazzi C; Fagniez N; Fau JB; Koiwai K; Ziti-Ljajic S; Veyrat-Follet C
    J Clin Pharmacol; 2017 Jul; 57(7):865-875. PubMed ID: 28138963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal pharmacokinetics and interspecies scaling from animals to man of lamifiban, a new platelet aggregation inhibitor.
    Lave T; Saner A; Coassolo P; Brandt R; Schmitt-Hoffmann AH; Chou RC
    J Pharm Pharmacol; 1996 Jun; 48(6):573-7. PubMed ID: 8832489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned?
    Deng R; Iyer S; Theil FP; Mortensen DL; Fielder PJ; Prabhu S
    MAbs; 2011; 3(1):61-6. PubMed ID: 20962582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.